Colforsin dapropate

Drug Profile

Colforsin dapropate

Alternative Names: Adehl; Colforsin daropate hydrochloride; NKH 477

Latest Information Update: 27 Aug 2007

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nippon Kayaku
  • Class Diterpenes; Heart failure therapies
  • Mechanism of Action Adenylate cyclase stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Acute heart failure
  • Discontinued Asthma

Most Recent Events

  • 27 Aug 2007 Discontinued - Preclinical for Asthma in Japan (IV)
  • 28 Nov 2002 A study has been added to the Obstructive Airways Disease therapeutic trials section
  • 03 Mar 2000 Launched for Acute heart failure (Treatment-experienced) in Japan (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top